H1ghlander77

The path of the righteous man is beset on all sides by the inequities of the selfish and the tyranny of evil men

[H1ghlander77 @H1ghlander77]

@May4yg5 @RezolveAi 🥱

[H1ghlander77 @H1ghlander77]

push is accelerating the exact shift toward "agentic shopping" that is driving Rezolve's projected $360 million revenue target.

[H1ghlander77 @H1ghlander77]

@realDanWagner @RezolveAi
Interesting chat with AI
Thoughts?
They operate in the same broader universe of Agentic Commerce (AI buying items on behalf of humans), but SpaceXAI and Rezolve AI (RZLV) are not direct rivals.
​They are building completely different sides of the

[H1ghlander77 @H1ghlander77]

consumer's intent (the wallet and the request). Rezolve AI is successfully positioning itself as the enterprise infrastructure (the cash register and the inventory brain) for over 1,000 global merchants.
​Instead of hurting Rezolve, the massive hype from the SpaceXAI e-commerce

[H1ghlander77 @H1ghlander77]

@lining9711 @RezolveAi @realDanWagner @adammendler If you had done your research when they got into the russel index via spac merger, you would if known they was going to be deleted during the reviews being a uk company.
Its already priced in 👍

[H1ghlander77 @H1ghlander77]

@RezolveAi Validating exactly what you have said. Massive ❤️

[H1ghlander77 @H1ghlander77]

@MrMarketValue @RezolveAi @realDanWagner @goimplementai @pierslinney @Aalokyshukla Read the recent filings?

[H1ghlander77 @H1ghlander77]

@Rami580311 @RezolveAi 🥱

[MarketMaverick @DiaTSLAPLTR]

THE $RZLV / $CMRC HOSTILE TAKEOVER: MY FAIR ASSESSMENT

@realDanWagner dropped a full thread today making the case for Rezolve's hostile bid for https://t.co/7datntPfwf. I've been covering $RZLV for months, read the 20F, listened to the earnings call, and now I've pulled CMRC's actual financials to score this deal. Here's what the posts are getting right, what's being glossed over, and what serious investors should actually focus on. Neither pump nor bash just the math.

"WHAT DAN IS GETTING RIGHT"

1. The accretive math is real.
CMRC reported $342.3M in audited 2025 revenue, $359.1M ARR, $27.4M in positive operating cash flow, and 78% GAAP gross margin. If Rezolve acquires this with sub-10% equity dilution, the per-share economics are undeniably accretive. You don't often get 7x your revenue base for less than 10% dilution.

2. CMRC's profitability fills Rezolve's biggest hole.
This is the point most $RZLV bulls haven't fully absorbed. Rezolve burned $63M in operating cash in 2025. CMRC generated $27M POSITIVE operating cash flow plus $50M annual profit per Dan's numbers. If this closes, the combined entity instantly shifts from cash-burning to self-funding. That single line item removes the largest bear thesis on Rezolve overnight.

3. The strategic fit is genuine.
60,000+ BigCommerce merchants would become immediate distribution for RezolvePay, Brain Commerce, and the agentic checkout infrastructure. Feedonomics adds a product data layer that complements GroupBy. Makeswift adds visual editing that stacks with Crownpeak. This isn't a random acquisition, it's a vertical consolidation of the enterprise commerce stack under one roof.

4. Pulling the 1-for-1 offer was disciplined.
Walking from a richer offer when the board refuses to engage sends the correct signal to Rezolve's own cap table. The 0.5 ratio reflects fundamentals-based valuation, not panic buying. That's how serious operators negotiate.

5. CMRC's growth profile is weak, Dan's numbers are accurate.
3% YoY ARR growth, 96% decline since 2020 IPO, enterprise logo churn. These are real data points from CMRC's own filings. The "transformation" narrative the CMRC board is pushing isn't supported by the growth numbers.

"WHAT'S BEING GLOSSED OVER"

1. The 2:1 ratio values CMRC BELOW current market.
Here's the math nobody's saying out loud. At RZLV ~$2.85 and a 0.5 exchange ratio, each CMRC share is being offered $1.42 in Rezolve stock. CMRC currently trades at ~$2.74. That's a ~48% discount to market. Dan frames this as "acquiring at a disciplined valuation." CMRC shareholders will frame it as "selling their stock for half price." Both are accurate. The board's rejection wasn't just arrogance ,they have a fiduciary duty not to accept offers below market value without a compelling reason.

2. Hostile takeovers rarely close quickly.
Proxy fights take months. Shareholder tender offers require regulatory filings, disclosure documents, and a majority vote. Even when hostile bids succeed, they typically require the bidder to raise the offer multiple times. The $700M combined entity thesis is real, but it assumes a closing that may take 6-12+ months or may never happen at all. Investors should price in execution risk, not just outcome math.

3. Rezolve hasn't yet proven it can integrate what it already bought.
The 20F disclosed four material weaknesses in internal controls during a year when Rezolve acquired GroupBy, Crownpeak, Subsquid, Bluedot, Smartpay, and Prediqt. Reward closed in February 2026. Adding CMRC's $342M revenue, 1,500+ employees, Austin headquarters, and 60K merchant base before the existing acquisitions are fully integrated is operational ambition at maximum velocity. Integration quality is the single biggest risk on this stock, and CMRC would multiply it.

4. CMRC's slow growth could drag Rezolve's multiple.
This is subtle but important. Rezolve trades partly on hypergrowth narrative, 543% H2 acceleration, $232M ARR exit, 7.5x guided 2026 growth. CMRC grows at 3%. Blending a 3% grower with a 700%+ grower will mathematically lower the combined entity's growth rate. The market may re-rate the combined entity DOWN in multiple terms even as revenue goes UP in absolute terms. This is the tradeoff nobody is modeling publicly yet.

5. Dan's tone is escalating, and that matters in proxy fights.
"Zombie stock," "boardroom arrogance," "playing games," "expensive advisors protecting seats." These lines play well on Twitter but can hurt in front of institutional CMRC holders who will decide this deal. Proxy fights are won by appealing to the shareholders' economic interest calmly and methodically, not by attacking the board personally. The CMRC institutional base includes names like Vanguard, BlackRock, and Fidelity. They don't respond well to emotional rhetoric.

THE REAL BOTTOM LINE

This deal is strategically sound and financially accretive IF it closes at the proposed ratio. That's a big if.

For $RZLV holders: the ceiling is higher if this closes, but the floor is also lower because execution bandwidth gets stretched. For $CMRC holders: the liquidity argument is real, the 96% decline is real, but so is the math showing they'd be accepting a discount to market.

My honest take: this is a high conviction, high-risk move that reflects exactly the kind of aggressive capital deployment Dan has been signaling since the 20F. I respect the ambition. I'm long $RZLV and staying long. But I'm also watching for the three things that matter most in the next 30 days:

1. Does the CMRC institutional base publicly respond? Silence means they're listening.
2. Does Rezolve sweeten the ratio? That would signal the 2:1 was a negotiating floor, not a final offer.
3. Does Q1 2026 revenue track toward the $360M annual guide? If execution slips while management is distracted by a proxy fight, that's the real risk.

Narrative is easy. Execution is hard. The next quarter tells you which one wins.

$RZLV $CMRC $AgenticCommerce

[MarketMaverick @DiaTSLAPLTR]

🧵2/2

6-POWA TECHNOLOGIES PARALLELS "Concern: CEO's prior venture collapsed after $200M+ in investor losses"

INDIRECTLY ADDRESSED. The 20F is filed, audited GAAP revenue is $46.8M, named clients are listed (Target, GAP, Dunkin', Coles, Mango, DFS, etc.), Microsoft/Google/Tether executives gave public endorsements in the annual report. The substance is different from Powa.

However, the material weaknesses in internal controls during a rapid acquisition phase are exactly the type of structural vulnerability that created problems at Powa. The remediation plan matters.

7-CASH POSITION & DILUTION "Concern: Thin cash after Reward acquisition"
✅ ADDRESSED. End of 2025: $111.1M cash. January 2026: +$250M raised. February 2026: -$230M for Reward. Estimated post-Reward cash: ~$131M.

The 20F also reveals $102M in short-term debt (primarily from Crownpeak acquisition) that needs refinancing, watch this.

8- THE $63.3M IMPAIRMENT "This was new and I flagged it in my post earnings breakdown."

✅ EXPLAINED. The 20F confirms: the $63.3M impairment charge is entirely related to SQD (Subsquid) token holdings. After acquiring Subsquid, the SQD token price declined significantly through year-end 2025. This is a non-cash write-down on a crypto asset, not an operating impairment. It doesn't affect revenue or cash flow. However, there's risk of further impairment if SQD tokens keep declining.

9- EARNINGS CALL WITH OPEN Q&A "Concern: Would they hold a real call or just drop a press release?"

✅ DELIVERED. Full earnings call at 8:30am ET with Dan Wagner and Arthur Yao. Four sell-side analysts asked questions (Maxim Group, Alliance Global Partners, Northland Capital, Roth Capital). Topics covered: sales cycle acceleration, RezolvePay/Tether timeline, organic vs M&A mix, margin trajectory, EBITDA outlook, pricing dynamics. Open Q&A format.

FINAL SCORECARD:
✅ GAAP Revenue: Confirmed, beat by 17%
✅ Organic vs Acquired: First real breakdown: ~$142M organic/partnership vs ~$90M acquired
✅ Headcount & Scale: 1,000+ employees, 32 offices
✅ Cash Position: ~$131M post-Reward, no operational dilution pledge
✅ Earnings Call: Full Q&A delivered
✅ Impairment: Explained (SQD tokens, non-cash)

Watching the following and will update you:
1- Going Concern: Language present but mitigated by $250M raise
2- Material Weaknesses: Four identified, remediation underway
3- Related Party: Significantly reduced YoY but DBLP consultancy still active
4- Short Term Debt: $102M needs refinancing in 2026
Governance Structure: Still no Chairman/CEO separation

BOTTOM LINE:
6 months ago, I called this a binary outcome stock. Today, the needle has moved decisively toward the bull case. $46.8M audited GAAP revenue, $19.4M December MRR in the 20-F, 543% H2 acceleration, named enterprise clients, hyperscaler endorsements, and a CEO who showed up on an earnings call and took questions. But, material weaknesses in internal controls during a year where the company did 5+ acquisitions is real risk. The going concern language, while standard, exists. And $102M in short term debt needs managing.

The stock still has two paths, but the probability weighting has shifted. If Q1/Q2 2026 revenue tracks toward the $360M annual guide and Reward integration goes smoothly, the market will rerate this. At ~$1.1B market cap with $360M guided and $90M from Reward alone, the math is compelling.

I'll keep watching. I'll keep reading filings. And I'll keep posting what I find, bull or bear.

Still long. Conviction is rising. I’m holding my position and added more shares today (04/01/2026) from selling half of one position. DYOR

Big Thanks to @realDanWagner and $RZLV team for all your effort.. Keep doing great work!

[H1ghlander77 @H1ghlander77]

@RezolveAi #love